Ketone strong: Emerging evidence for a therapeutic role of ketone bodies in neurological and neurodegenerative diseases

Journal of Lipid Research

Volumn 55, Issue 9, 2014, Pages 1815-1817

  Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETONE BODY;

ANIMAL; DEGENERATIVE DISEASE; ENERGY METABOLISM; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY;

ANIMALS; ENERGY METABOLISM; HUMANS; KETONE BODIES; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84906855174     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E052944     Document Type: Editorial

References (29)

1. de Carvalho Vidigal, F., P. Guedes Cocate, L. Goncalves Pereira, and R. de Cassia Goncalves Alfenas. 2012. The role of hyperglycemia in the induction of oxidative stress and inflammatory process. Nutr. Hosp. 27: 1391-1398.
2. Longo, V. D., and M. P. Mattson. 2014. Fasting: molecular mechanisms and clinical applications. Cell Metab. 19: 181-192.
3. Shelton, H. M. 1974. Fasting for Renewal of Life. American Natural Hygiene Society, Inc., Tampa, FL.
4. Owen, O. E., A. P. Morgan, H. G. Kemp, J. M. Sullivan, M. G. Herrera, and G. F. Cahill, Jr. 1967. Brain metabolism during fasting. J. Clin. Invest. 46: 1589-1595.
5. Weindruch, R., R. L. Walford, S. Fligiel, and D. Guthrie. 1986. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr. 116: 641-654. (Pubitemid 16066430)
6. Lin, Y., A. H. Berg, P. Iyengar, T. K. Lam, A. Giacca, T. P. Combs, M. W. Rajala, X. Du, B. Rollman, W. Li, et al. 2005. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 280: 4617-4626. (Pubitemid 40288630)
7. Hayflick, L. 2007. Entropy explains aging, genetic determinism explains longevity, and undefined terminology explains misunderstanding both. PLoS Genet. 3: e220.
8. Veech, R. L. 2004. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 70: 309-319. (Pubitemid 38200957)
9. Mahoney, L. B., C. A. Denny, and T. N. Seyfried. 2006. Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans. Lipids Health Dis. 5: 13.
10. Cahill, G. F., Jr. 2006. Fuel metabolism in starvation. Annu. Rev. Nutr. 26: 1-22.
11. Cervenka, M. C., B. Henry, J. Nathan, S. Wood, and J. S. Volek. 2013. Worldwide dietary therapies for adults with epilepsy and other disorders. J. Child Neurol. 28: 1034-1040.
12. Meidenbauer, J. J., N. Ta, and T. N. Seyfried. 2014. Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice. Nutr. Metab. (Lond). 11: 23.
13. Freeman, J. M., and E. H. Kossoff. 2010. Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv. Pediatr. 57: 315-329.
14. Mantis, J. G., N. A. Centeno, M. T. Todorova, R. McGowan, and T. N. Seyfried. 2004. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr. Metab. (Lond). 1: 11.
15. Seyfried, T. N., R. E. Flores, A. M. Poff, and D. P. D'Agostino. 2014. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis. 35: 515-527.
16. Zhou, W., P. Mukherjee, M. A. Kiebish, W. T. Markis, J. G. Mantis, and T. N. Seyfried. 2007. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr. Metab. (Lond). 4: 5.
17. Shimazu, T., M. D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C. A. Grueter, H. Lim, L. R. Saunders, R. D. Stevens, et al. 2013. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 339: 211-214.
18. Clarke, K., K. Tchabanenko, R. Pawlosky, E. Carter, M. Todd King, K. Musa-Veloso, M. Ho, A. Roberts, J. Robertson, T. B. Vanitallie, et al. 2012. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul. Toxicol. Pharmacol. 63: 401-408.
19. Hashim, S. A., and T. B. Vanitallie. Ketone body therapy: from ketogenic diet to oral administration of ketone ester. J. Lipid Res. Epub ahead of print. March 20, 2014; doi:10.1194/jlr.R046599.
20. Veech, R. L. Ketone ester effects on metabolism and transcription. J. Lipid Res. Epub ahead of print. April 8, 2014; doi:10.1194/jlr.R046292.
21. Gano, L., M. Patel, and J. M. Rho. Ketogenic diets, mitochondria and neurological diseases. J. Lipid Res. Epub ahead of print. May 20, 2014; doi:10.1194/jlr.R048975.
22. Prins, M., and J. Matsumoto. The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury. J. Lipid Res. Epub ahead of print. April 10, 2014; doi:10.1194/jlr.R046706.
23. Seyfried, T. N. R. Flores, A. M. Poff, D. P. D'Agostino, and P. Mukherjee. 2014. Metabolic therapy: a new paradigm for managing malignant brain cancer. Cancer Lett. (in press).
24. Woolf, E. C., and A. C. Scheck. The ketogenic diet for the treatment of malignant glioma. J. Lipid Res. Epub ahead of print. February 6, 2014; doi:10.1194/jlr.R046656.
25. Seyfried, T. N., J. G. Mantis, M. T. Todorova, and A. E. Greene. 2009. Dietary management of epilepsy: role of glucose and ketone bodies. In Encyclopedia of Basic Epilepsy Research, Vol. 2. P. A. Schwartzkroin, editor. Academic Press, Oxford. 687-693.
26. Seyfried, T. N., M. A. Kiebish, J. Marsh, L. M. Shelton, L. C. Huysentruyt, and P. Mukherjee. 2011. Metabolic management of brain cancer. Biochim. Biophys. Acta. 1807: 577-594.
27. Cahill, G. F., Jr., and R. L. Veech. 2003. Ketoacids? Good medicine? Trans. Am. Clin. Climatol. Assoc. 114: 149-161; discussion 162-143.
28. Davies, B., and T. Morris. 1993. Physiological parameters in laboratory animals and humans. Pharm. Res. 10: 1093-1095. (Pubitemid 23211439)
29. Seyfried, T. N., M. Kiebish, P. Mukherjee, and J. Marsh. 2008. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets. Epilepsia. 49 (Suppl 8): 114-116.